These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27489104)

  • 1. The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs.
    Kohda A; Yamazaki S; Sumimoto H
    J Biol Chem; 2016 Sep; 291(39):20739-52. PubMed ID: 27489104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA element downstream of the κB site in the Lcn2 promoter is required for transcriptional activation by IκBζ and NF-κB p50.
    Kohda A; Yamazaki S; Sumimoto H
    Genes Cells; 2014 Aug; 19(8):620-8. PubMed ID: 24948478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and biochemical analyses of the nuclear IκBζ protein in complex with the NF-κB p50 homodimer.
    Zhu N; Rogers WE; Heidary DK; Huxford T
    Genes Dev; 2024 Jul; 38(11-12):528-535. PubMed ID: 38960718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the Interaction of B Cell Leukemia 3 (BCL-3) and Nuclear Factor κB (NF-κB) p50 Identifies a BCL-3-mimetic Anti-inflammatory Peptide.
    Collins PE; Grassia G; Colleran A; Kiely PA; Ialenti A; Maffia P; Carmody RJ
    J Biol Chem; 2015 Jun; 290(25):15687-15696. PubMed ID: 25922067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling-based evaluation of dual function of IκBζ ankyrin repeat domain in toll-like receptor signaling.
    Manavalan B; Govindaraj R; Lee G; Choi S
    J Mol Recognit; 2011; 24(4):597-607. PubMed ID: 21472811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective regulation of a defined subset of inflammatory and immunoregulatory genes by an NF-κB p50-IκBζ pathway.
    Daly AE; Yeh G; Soltero S; Smale ST
    Genes Dev; 2024 Jul; 38(11-12):536-553. PubMed ID: 38918046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
    Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A
    Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.
    Collins PE; Kiely PA; Carmody RJ
    J Biol Chem; 2014 Mar; 289(10):7059-7067. PubMed ID: 24459141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function relationship of cytoplasmic and nuclear IκB proteins: an in silico analysis.
    Manavalan B; Basith S; Choi YM; Lee G; Choi S
    PLoS One; 2010 Dec; 5(12):e15782. PubMed ID: 21203422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal domain of IkappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers.
    Latimer M; Ernst MK; Dunn LL; Drutskaya M; Rice NR
    Mol Cell Biol; 1998 May; 18(5):2640-9. PubMed ID: 9566883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3.
    Wu CL; Kandarian SC; Jackman RW
    PLoS One; 2011 Jan; 6(1):e16171. PubMed ID: 21249144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta.
    Yamamoto M; Yamazaki S; Uematsu S; Sato S; Hemmi H; Hoshino K; Kaisho T; Kuwata H; Takeuchi O; Takeshige K; Saitoh T; Yamaoka S; Yamamoto N; Yamamoto S; Muta T; Takeda K; Akira S
    Nature; 2004 Jul; 430(6996):218-22. PubMed ID: 15241416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a ternary complex of NF-kappaB and IkappaBalpha with DNA provides insights into how IkappaBalpha removes NF-kappaB from transcription sites.
    Sue SC; Alverdi V; Komives EA; Dyson HJ
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1367-72. PubMed ID: 21220295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas.
    Mathas S; Jöhrens K; Joos S; Lietz A; Hummel F; Janz M; Jundt F; Anagnostopoulos I; Bommert K; Lichter P; Stein H; Scheidereit C; Dörken B
    Blood; 2005 Dec; 106(13):4287-93. PubMed ID: 16123212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.
    Matthews JR; Watson E; Buckley S; Hay RT
    Nucleic Acids Res; 1993 Sep; 21(19):4516-23. PubMed ID: 7694229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
    Thornburg NJ; Pathmanathan R; Raab-Traub N
    Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
    Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin receptor substrate-3, interacting with Bcl-3, enhances p50 NF-kappaB activity.
    Kabuta T; Hakuno F; Cho Y; Yamanaka D; Chida K; Asano T; Wada K; Takahashi S
    Biochem Biophys Res Commun; 2010 Apr; 394(3):697-702. PubMed ID: 20226764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members.
    Jiang HY; Petrovas C; Sonenshein GE
    J Virol; 2002 Jun; 76(11):5737-47. PubMed ID: 11992002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction.
    Dooher JE; Paz-Priel I; Houng S; Baldwin AS; Friedman AD
    Mol Cancer Res; 2011 Oct; 9(10):1395-405. PubMed ID: 21813505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.